Bell Palsy

• Viral reactivation and inflammatory cascade: Herpes simplex virus 1 (HSV-1) and varicella-zoster virus (VZV) are implicated as primary infectious triggers, though the mechanism remains incompletely understood. These viruses likely reactivate from latency within the geniculate ganglion of the facial nerve, triggering acute inflammation and recruitment of T lymphocytes and macrophages. The inflammatory response produces cytokines (TNF-α, IL-1, IL-6) that cause focal edema of the nerve. This edema is pathognomonic because the facial nerve travels through a rigid bony canal (Fallopian canal) with minimal distensibility; even modest swelling (10-50%) leads to ischemia of nerve fibers due to microvascular compression and increased intraneural pressure exceeding capillary perfusion pressure. The resulting ischemia impairs axonal conduction, leading to acute denervation of facial musculature within hours to days.

• Axonal degeneration and neurophysiological consequences: The degree of nerve injury ranges from neuropraxia (demyelination with intact axonal continuity, seen in ~85% of cases) to axonotmesis (axonal disruption, seen in ~15% of cases). In neuropraxia, conduction block occurs due to segmental demyelination, but because the axon is preserved, spontaneous remyelination allows recovery over weeks to months. In axonotmesis, axonal degeneration occurs distal to the lesion (Wallerian degeneration), requiring regeneration of nerve fibers at a rate of approximately 1 mm/day, translating to several months for complete reinnervation of facial muscles. The anatomical course of the facial nerve—with its complex three-dimensional routing through the temporal bone, multiple branches, and multiple motor end plates—means that even partial denervation causes clinically apparent facial asymmetry. Electromyography reveals fibrillations and positive sharp waves within 3-5 days in axonotmesis cases, representing spontaneous muscle fiber depolarization from denervation.

• Ischemic injury from increased compartment pressure: The Fallopian canal constrains the facial nerve in a fixed space approximately 25-35 mm in length. Inflammatory edema increases intraneural pressure, which compromises microvascular perfusion at pressures exceeding 30 mmHg—well below normal diastolic blood pressure in capillaries. This ischemia affects nerve conduction velocity and amplitude disproportionately in larger diameter fibers first, explaining why motor function is preferentially affected before sensory function (even though the facial nerve carries both modalities via the greater petrosal and chorda tympani branches). The ischemic environment also creates oxidative stress through hypoxia-inducible factor activation and reactive oxygen species production, which can potentiate inflammation and contribute to incomplete recovery in some patients.

• Loss of facial motor unit recruitment and muscular consequences: The facial nerve innervates 20 pairs of muscles controlling facial expression, with particularly important functions in eye closure (orbicularis oculi) and mouth movements (orbicularis oris, buccinator). Loss of motor innervation leads to flaccid paralysis initially, though some patients develop aberrant regeneration and synkinesis (involuntary facial movements accompanying voluntary movement of another facial region) during recovery. The unopposed action of contralateral facial muscles creates the characteristic facial asymmetry and inability to smile or wrinkle the forehead on the affected side. Importantly, loss of eyelid closure leads to corneal exposure and risk of exposure keratopathy, making eye care a critical component of management.

• Idiopathic viral reactivation (primary mechanism): Approximately 60-75% of cases are considered truly idiopathic Bell palsy, thought to result from reactivation of herpes viruses (HSV-1 in ~45%, VZV in ~10%, or both). The mechanism of reactivation may involve immunosuppression from concurrent viral illness, stress, or underlying immune dysfunction. Recent data suggests that even cases labeled "idiopathic" have evidence of HSV-1 in the facial nerve ganglia, supporting a viral etiology for the majority of cases. The virus triggers not just local inflammation but also may cause direct cytolytic damage to nerve fibers and supporting Schwann cells.

• Metabolic and endocrine risk factors: Diabetes mellitus significantly increases risk (relative risk 2-4 fold), with both type 1 and type 2 diabetes conferring increased susceptibility, possibly through impaired microvascular perfusion and reduced tissue resilience. Pregnancy, particularly in the third trimester and early postpartum period, carries substantially increased risk (up to 3 times baseline). Hypothyroidism has been reported as a risk factor, though the mechanism is unclear. These metabolic conditions may impair local immune responses or reduce vascular compensation for intraneural edema, making nerves more vulnerable to ischemic injury.

• Immunosuppression and systemic disease associations: HIV infection increases Bell palsy risk (relative risk 3-10 fold depending on CD4 count), with higher rates in patients with CD4 <200 cells/μL. Patients receiving immunosuppressive therapy (corticosteroids, TNF-inhibitors, checkpoint inhibitors) have increased incidence. Systemic conditions including sarcoidosis (which causes Heerfordt syndrome: facial nerve palsy with parotitis and uveitis), Lyme disease (Borrelia burgdorferi), leprosy, and tuberculosis can present as facial nerve paralysis, though these are technically secondary causes and should be excluded in the diagnostic evaluation.

• Acute concurrent viral illness: Recent upper respiratory viral infection, particularly influenza, increases risk. This may relate to systemic immune activation that triggers latent viral reactivation or the inflammatory milieu that predisposes to nerve ischemia. Similarly, recent vaccination (particularly influenza vaccine, though causation is debated) has been associated with Bell palsy in some series.

• Genetic predisposition: Family history of Bell palsy (present in 4-8% of patients) suggests inherited predisposition, possibly involving immune recognition genes or factors affecting microvascular response to inflammation. Caucasians have higher incidence than African Americans in some series, suggesting ethnic-genetic factors.

• Secondary causes that mimic Bell palsy (must be excluded): Bilateral facial nerve paralysis (suggesting Lyme disease, sarcoidosis, HSV-2, leukemia, or lymphoma), facial nerve palsy with otitis media (suggesting otologic infection), parotid gland pathology causing compression, temporal bone fracture, intracranial mass compressing CN VII, or facial nerve involvement in Bell phenomenon variants all suggest secondary etiologies requiring investigation beyond standard Bell palsy management.

• Acute onset facial asymmetry and weakness: The hallmark presentation is sudden or rapid onset (over hours to 48 hours) of unilateral facial weakness, often maximal at presentation or worsening over the first 24-48 hours. Patients report inability to smile on the affected side, with the face appearing pulled toward the unaffected side. Unlike central facial weakness from stroke (which spares forehead and eye closure due to bilateral innervation of these muscles), Bell palsy causes complete facial weakness including forehead wrinkling loss and eye closure impairment. The weakness is flaccid rather than spastic, distinguishing peripheral from central causes. Patients often report that the entire side of their face feels "heavy" or "thick."

• Loss of eye closure and corneal exposure risk: Paralysis of the orbicularis oculi muscle eliminates the ability to close the eye on the affected side, creating the clinically dangerous sign of eye exposure during sleep. Patients often wake with tears and ocular discomfort. The "bell sign" (upward deviation of the eye when attempting closure) occurs because the levator palpebrae superioris still functions, rolling the eye up while the paralyzed orbicularis oculi cannot achieve closure. Loss of corneal sensation (mediated by CN V) is NOT present in Bell palsy (this is a key distinguishing feature), so corneal reflexes remain intact, though blink reflex afferent arc will be abnormal on the affected side.

• Loss of forehead wrinkling and eyebrow elevation: Unlike stroke, which preserves forehead movements due to bilateral corticobulbar innervation, Bell palsy eliminates forehead wrinkling on the affected side. This is clinically tested by asking the patient to raise eyebrows or wrinkle the forehead. Asymmetric eyebrow elevation is an extremely helpful distinguishing feature of peripheral nerve involvement.

• Oral commissure deviation and eating dysfunction: The unopposed action of contralateral orbicularis oris and zygomaticus muscles causes the mouth to deviate toward the unaffected side, exaggerated when smiling or puckering lips. Patients may report difficulty eating or drinking on the affected side, with food pooling in the affected cheek and drooling. Some patients report altered taste from involvement of the chorda tympani branch carrying taste fibers from anterior 2/3 of tongue.

• Pain and hyperacusis: Approximately 25-60% of patients experience pain, most commonly behind the ear or in the postauricular region, sometimes preceding paralysis onset by hours to days. This pain is thought to reflect inflammatory swelling within the facial nerve canal and mastoid region. Hyperacusis (heightened sensitivity to sound) occurs in approximately 25% of patients from paralysis of the stapedius muscle, which normally dampens stapes oscillation; sounds appear uncomfortably loud on the affected side. The combination of peripheral facial paralysis with preauricular pain should heighten suspicion for VZV-associated Ramsay Hunt syndrome, though classic vesicular eruption may be delayed or absent.

• Prodromal symptoms: Some patients report prodromal symptoms 24-72 hours preceding paralysis onset, including vague malaise, myalgias, or low-grade fever, supporting the viral etiology hypothesis.

• Physical examination findings:
• Facial droop: Observable drooping of the affected side, accentuated when the patient smiles or attempts facial movements
• Inability to close eye on affected side: Important finding to document and photograph for medicolegal purposes; assess Bell sign
• Asymmetric forehead wrinkling: Loss of horizontal wrinkles when raising eyebrows on the affected side
• Asymmetric nasolabial fold: Flattening of the nasolabial fold on affected side due to paresis of orbicularis oris and buccinator
• Oral commissure deviation: Mouth deviates away from the affected side, especially when smiling
• Normal corneal sensation: Distinguishes peripheral from central lesions; corneal reflex afferent arc normal (CN V)
• Intact motor function of other cranial nerves: Pupils reactive, tongue midline, pharyngeal function normal (assessing CN II, III, XII, and IX-X)

• Important clinical variants:
• Crocodile tears (lacrimation during eating): Represents aberrant regeneration of parasympathetic fibers intended for salivary glands now innervating lacrimal gland; typically emerges weeks after initial paralysis during recovery phase
• Synkinesis: Involuntary facial movements accompanying attempted voluntary movement of another facial region (e.g., eye closure occurring with mouth movement); emerges during recovery from partial denervation and aberrant regeneration
• Ramsay Hunt syndrome: Bell palsy variant associated with VZV presenting with facial paralysis, vesicular eruption in ear canal or soft palate, and often more severe paralysis with poorer prognosis

• Clinical diagnostic criteria: Bell palsy is diagnosed when a patient presents with acute-onset unilateral peripheral facial nerve paralysis (House-Brackmann grade II-VI) without alternative explanation. Key diagnostic features include: (1) sudden onset over hours to 2 days, (2) unilateral distribution affecting forehead and eye closure (distinguishing from central stroke), (3) absence of other neurologic signs suggesting intracranial pathology, (4) intact sensation in the external ear canal and anterior 2/3 tongue (unless chorda tympani involvement), (5) normal pupillary responses and extraocular motility, and (6) no recent temporal bone trauma or otologic infection. The diagnosis is one of exclusion, requiring that secondary causes have been reasonably excluded through history and examination.

• House-Brackmann Facial Nerve Grading Scale: This validated 6-point scale quantifies severity and predicts prognosis:
• Grade I: Normal
• Grade II: Mild weakness (slight asymmetry at rest, symmetric movement with maximal effort)
• Grade III: Moderate weakness (obvious weakness at rest, asymmetric movement with effort)
• Grade IV: Moderately severe weakness (obvious resting asymmetry, incomplete eye closure)
• Grade V: Severe paralysis (only slight movement discernible, incomplete eye closure, mouth asymmetry at rest)
• Grade VI: Complete paralysis (no movement on affected side)

• Electrodiagnostic testing (EMG and nerve conduction studies) aids prognosis and confirms axonotmesis:
• Electromyography (EMG): Fibrillations and positive sharp waves appearing 3-5 days after paralysis onset indicate axonotmesis (axonal degeneration). Absence of fibrillations in first 3-5 days indicates neuropraxia. Reduced motor unit recruitment and short-duration, small-amplitude motor units indicate severe denervation. EMG findings have prognostic value: patients with >90% reduction in motor unit action potential recruitment have <10% chance of complete spontaneous recovery without intervention.
• Nerve conduction studies (NCS): Significant reduction in compound motor action potential (CMAP) amplitude on stimulation of the affected facial nerve compared to the unaffected side (>75% reduction indicates severe denervation) predicts poorer prognosis. Decreased CMAP amplitude by >50% is associated with higher risk of incomplete recovery and residual weakness/synkinesis.

• Imaging considerations:
• High-resolution CT temporal bone: Not routinely indicated for uncomplicated Bell palsy but warranted if clinical presentation is atypical (bilateral paralysis, slowly progressive weakness, recurrent Bell palsy, or signs suggesting otologic infection or temporal bone fracture). CT can identify fractures, cholesteatoma, or parotid pathology.
• MRI with gadolinium: Demonstrates facial nerve enhancement within the temporal bone and brainstem in Bell palsy, though this is a nonspecific finding. MRI is not routinely needed for diagnosis but may be indicated to exclude intracranial mass or brainstem pathology if clinical suspicion is high (progressive weakness, other neurologic deficits, or atypical features).
• Imaging findings: Typical Bell palsy shows enhancement of the facial nerve within the Fallopian canal (from geniculate ganglion to stylomastoid foramen) and sometimes enhancing parotid gland involvement. Enhancement alone does not indicate disease severity or prognosis.

• Laboratory testing and special studies:
• Lyme serology (anti-Borrelia burgdorferi antibodies, confirmed by Western blot): Indicated when Bell palsy occurs in endemic areas for Lyme disease (northeastern United States, particularly during tick season). Lyme-associated facial paralysis may occur

Immediate priority — protect the cornea

• Ocular surface protection: incomplete lid closure plus loss of the blink reflex efferent arc causes tear film evaporation and exposure keratopathy. The American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS) Bell's palsy guideline makes eye care a strong recommendation for any patient with incomplete eye closure: preservative-free artificial tears during the day, lubricating ointment at night, and taping the lid shut or using a moisture chamber during sleep. Urgent ophthalmology referral if pain, redness, or visual change develops.

First-line pharmacotherapy

• Oral corticosteroids (representative agent: prednisone, typically 60 mg daily for about a week; prednisolone is used interchangeably): suppress the cytokine-driven intraneural edema that generates compartment ischemia within the Fallopian canal. Both AAO-HNS and the American Academy of Neurology (AAN) support steroids started within 72 hours of symptom onset in patients ≥16 years; benefit falls off sharply after that window. Steroids increase the probability of complete recovery and reduce synkinesis.
• Antivirals as add-on only: valacyclovir (or acyclovir) in combination with steroids may be offered, particularly in severe (House-Brackmann V–VI) paralysis, on the rationale of HSV-1/VZV reactivation. AAN characterizes the added benefit as small at best.

Escalation and special situations

• Ramsay Hunt syndrome: vesicles in the ear canal or palate mandate full-dose antiviral plus steroid, not steroid alone, and warrants audiologic/vestibular assessment.
• Lyme-associated palsy: treat the infection (doxycycline per IDSA) rather than as idiopathic Bell palsy.
• Persistent paralysis beyond several months: refer to facial nerve specialists for physical therapy/neuromuscular retraining, botulinum toxin for synkinesis, upper-lid gold weight or tarsorrhaphy, and static or dynamic reanimation surgery.

What not to do

• Antiviral monotherapy: explicitly recommended against by AAO-HNS.
• Routine laboratory testing, routine imaging, and routine electrodiagnostics in typical new-onset cases.
• Surgical facial nerve decompression: evidence is insufficient; AAO-HNS makes no recommendation, and it is not standard care.
• Acyclovir without adequate hydration in renal impairment (crystal nephropathy risk).

Ocular — the emergencies

• Exposure keratopathy progressing to corneal ulceration or perforation: lagophthalmos plus reduced blink and, in some patients, reduced reflex tearing from greater petrosal nerve involvement leaves the cornea desiccated. Signaled by foreign-body sensation, injection, photophobia, or a fluorescein-staining epithelial defect. Pain with visual blurring is a same-day ophthalmology problem, since bacterial superinfection of an exposed cornea can destroy vision.

Neurologic sequelae of aberrant regeneration

• Synkinesis: regenerating axons reinnervate the wrong motor end plates, so voluntary smiling closes the eye or blinking twitches the corner of the mouth. Appears months into recovery and is the most common long-term complaint.
• **Crocodile tears (gustatory lacrimation)**: salivary parasympathetic fibers misroute to the lacrimal gland; unilateral tearing while eating.
• Hemifacial spasm and facial contracture: chronic ephaptic transmission and shortened denervated muscle produce a deepened nasolabial fold and narrowed palpebral fissure on the affected side — the face can look pulled toward the previously paralyzed side, a classic trap.
• Incomplete recovery: most likely with complete (House-Brackmann VI) paralysis, Ramsay Hunt syndrome, diabetes, and older age; carries measurable psychosocial and depressive morbidity.

Complications of therapy

• Corticosteroids: hyperglycemia (clinically important given the diabetes association), insomnia, mood change or frank psychosis, dyspepsia, and with repeated courses avascular necrosis of the femoral head.
• Acyclovir/valacyclovir: crystalline nephropathy with inadequate hydration or renal impairment; rarely neurotoxicity in renal failure.
• Gold weight or tarsorrhaphy: implant extrusion, astigmatism, cosmetic asymmetry.

Complications of misdiagnosis — flag as emergencies

• Missed stroke, brainstem lesion, or neoplasm: forehead sparing, other cranial nerve or long-tract signs, or weakness progressing beyond about three weeks demands imaging, not steroids.
• Bilateral facial palsy: think Guillain-Barré syndrome (monitor vital capacity and negative inspiratory force), Lyme disease, sarcoidosis, or leukemic infiltration — admit and investigate.

• Forehead involvement is the whole test: the upper face has bilateral corticobulbar input, so a lesion sparing the forehead is central (stroke) and one paralyzing the forehead is peripheral. Inability to wrinkle the brow plus lagophthalmos on the same side = CN VII nucleus or nerve, not cortex.
• Single best next step in a typical vignette: start oral corticosteroids (prednisone) within 72 hours and prescribe eye protection. Not MRI, not Lyme titers, not admission — AAO-HNS recommends against routine imaging and routine labs in new-onset unilateral palsy.
• Antiviral monotherapy is the classic wrong answer. Antivirals are add-on to steroids at most; steroids alone are never wrong, valacyclovir alone always is.
• **Vesicles in the external auditory canal or on the palate = *Ramsay Hunt syndrome*** (VZV, geniculate ganglion), which is more painful, more often associated with hearing loss and vertigo, and has a worse prognosis; it gets antiviral plus steroid.
• Bilateral facial palsy is never simple Bell palsy: think Lyme neuroborreliosis (the association examiners love — a child from Connecticut in summer with an expanding rash), Guillain-Barré, sarcoidosis (Heerfordt syndrome: uveoparotid fever), or HIV seroconversion.
• Localize by the associated symptoms: hyperacusis implicates the nerve to stapedius, altered taste on the anterior two-thirds of the tongue implicates chorda tympani, and dry eye implicates the greater petrosal nerve — all proximal to the stylomastoid foramen.
• Slowly progressive weakness over weeks, recurrent ipsilateral palsy, or a parotid mass points to neoplasm — image the temporal bone and parotid rather than repeating steroids.
• Facial sensation and the corneal reflex afferent limb are normal in Bell palsy because they are CN V; numbness of the face argues for another diagnosis.
• Prognosis pearl: most patients recover substantially, and incomplete (rather than complete) initial paralysis is the strongest favorable predictor.